BIOMARIN PHARMACEUTICAL INC Quarterly Interest Expense in USD from Q1 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Interest Expense history and growth rate from Q1 2010 to Q1 2024.
  • Biomarin Pharmaceutical Inc Interest Expense for the quarter ending March 31, 2024 was $3.55M, a 4.21% decline year-over-year.
  • Biomarin Pharmaceutical Inc Interest Expense for the twelve months ending March 31, 2024 was $17.2M, a 8.27% increase year-over-year.
  • Biomarin Pharmaceutical Inc annual Interest Expense for 2023 was $17.3M, a 8.55% increase from 2022.
  • Biomarin Pharmaceutical Inc annual Interest Expense for 2022 was $16M, a 4.13% increase from 2021.
  • Biomarin Pharmaceutical Inc annual Interest Expense for 2021 was $15.3M, a 47.7% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $17.2M $3.55M -$156K -4.21% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $17.3M $6.1M +$2.47M +68.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $14.9M $3.78M -$900K -19.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $15.8M $3.76M -$104K -2.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $15.9M $3.7M -$103K -2.71% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 $16M $3.63M -$220K -5.72% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $16.2M $4.68M +$809K +20.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $15.4M $3.86M +$42K +1.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $15.3M $3.81M +$2K +0.05% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $15.3M $3.85M -$903K -19% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $16.2M $3.87M -$5.73M -59.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $22M $3.82M -$4.23M -52.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $26.2M $3.8M -$3.11M -45% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $29.3M $4.75M -$2.18M -31.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $31.5M $9.6M +$6.66M +227% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $24.8M $8.05M +$1.18M +17.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $23.6M $6.92M +$188K +2.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $23.5M $6.93M -$816K -10.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $24.3M $2.94M -$9.19M -75.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $33.5M $6.87M -$5.36M -43.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $38.8M $6.73M -$4.84M -41.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $43.7M $7.75M -$3.92M -33.6% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $47.6M $12.1M +$1.25M +11.5% Jul 1, 2018 Sep 30, 2018 10-Q/A 2019-11-04
Q2 2018 $46.3M $12.2M +$2.19M +21.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 $44.2M $11.6M +$1.44M +14.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q4 2017 $42.7M $11.7M +$1.93M +19.9% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $40.8M $10.9M +$904K +9.06% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 $39.9M $10M +$96K +0.97% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $39.8M $10.1M +$276K +2.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q4 2016 $39.5M $9.73M +$399K +4.28% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $39.1M $9.98M +$533K +5.64% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 $38.6M $9.94M -$58K -0.58% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $38.6M $9.84M +$381K +4.03% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $38.2M $9.33M +$136K +1.48% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 $38.1M $9.45M +$329K +3.61% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $37.8M $10M +$781K +8.47% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $37M $9.46M +$356K +3.91% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 $36.6M $9.2M +$1.6M +21.1% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $35M $9.12M +$8.59M +1633% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 $26.4M $9.22M +$8.62M +1429% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $17.8M $9.11M +$7.38M +428% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 $10.4M $7.59M +$5.66M +293% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $4.78M $526K -$1.31M -71.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 $6.1M $603K -$1.32M -68.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 $7.42M $1.73M -$222K -11.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q4 2012 $7.64M $1.93M +$53K +2.82% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 $7.59M $1.84M -$331K -15.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-28
Q2 2012 $7.92M $1.93M -$276K -12.5% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-29
Q1 2012 $8.19M $1.95M -$216K -9.99% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-29
Q4 2011 $8.41M $1.88M -$869K -31.6% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-26
Q3 2011 $9.28M $2.17M -$840K -27.9% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-29
Q2 2011 $10.1M $2.2M -$434K -16.5% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-02
Q1 2011 $10.6M $2.16M -$266K -11% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-30
Q4 2010 $10.8M $2.75M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-26
Q3 2010 $3.01M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 $2.64M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-01
Q1 2010 $2.43M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.